Biotech IPOs in 2026: What Investors Want
2026 biotech IPOs: What do investors demand? Strong clinical data and clear commercialization paths are key for companies like GenePath.
AI and sustainability are redefining global Foreign Direct Investment. Learn how nations and companies attract capital, with $500B by 2028.